|
Payden & Rygel lessened its stake in Bristol-Myers Squibb (NYSE:BMY - Free
Report) by 98.2% in the 2nd quarter, according to its most recent... Bristol Myers Squibb, New York Stock Exchange, NYSE:BMY, Payden & Rygel, U.S. Securities and Exchange Commission |
| More about this | |
|
|
|
|
| |